Financial Instruments and Risk Management (Narrative) (Details) € in Millions, $ in Millions, SEK in Billions					3 Months Ended			12 Months Ended
		Nov. 20, 2015 USD ($)	Aug. 27, 2014 USD ($)	Apr. 03, 2013 USD ($)	Dec. 31, 2016 USD ($)	Jun. 30, 2016 USD ($)	Sep. 30, 2014 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)		Dec. 31, 2014 USD ($)	Dec. 31, 2016 SEK	Dec. 31, 2016 USD ($)		Nov. 29, 2016 USD ($)	Nov. 22, 2016 EUR (€)	Aug. 05, 2016 EUR (€)	Aug. 05, 2016 USD ($)	Jun. 24, 2016 USD ($)	Dec. 09, 2015 USD ($)	Sep. 17, 2015 USD ($)	Dec. 24, 2013 USD ($)	Dec. 04, 2013 USD ($)	Nov. 13, 2013	Jun. 18, 2013 USD ($)	Nov. 09, 2010
Derivative [Line Items]
Notional amount of derivative									$ 750.0			SEK 45.2	$ 750.0												$ 500.0
Maximum length of time hedged in cash flow hedge, in years								10 years
Debt instrument, interest rate, stated percentage																										6.00%
Amount of loss recognized in earnings on derivatives											$ 14.6
Amount of Gain or (Loss) Recognized in Earnings on Hedging Items											15.0
Aggregate principal amount																						$ 750.0
Debt instrument, interest rate at period end												1.30%	1.30%
Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months								$ 27.8
Payments for contingent consideration							$ 150.0	35.5	0.0		150.0
Purchase consideration, contingent consideration									526.4		470.0		$ 564.6										$ 230.0
Acquisitions		$ 22.8							18.0		80.0
Reclassifications								0.0	0.0
Restricted cash and cash equivalents													80.0
Accretion								41.8	38.4
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net								(104.5)	(29.5)		(78.3)
Compulsory acquisition proceeding liability																		$ 431.0
Contingent consideration payments								44.9
Fair value loss (gain)	[1]							18.9
Long-term Debt, Gross													15,522.0
Foreign currency translation								$ (0.4)
Minimum
Derivative [Line Items]
Rate used to discount net cash inflows to present values								0.90%
Accretion								$ 30.0
Maximum
Derivative [Line Items]
Rate used to discount net cash inflows to present values								9.80%
Accretion								$ 35.0
Meda AB
Derivative [Line Items]
Compulsory acquisition proceeding liability									0.0				70.2
Agila Specialties
Derivative [Line Items]
Purchase consideration, contingent consideration, maximum																							250.0
Contingent consideration payments								28.3
Jai Pharma Limited
Derivative [Line Items]
Purchase consideration, contingent consideration, maximum		$ 18.0
Fair value loss (gain)								12.6
Jai Pharma Limited | Minimum
Derivative [Line Items]
Rate used to discount net cash inflows to present values		10.00%
Jai Pharma Limited | Maximum
Derivative [Line Items]
Rate used to discount net cash inflows to present values		11.00%
Purchase consideration, contingent consideration, maximum		$ 50.0
Respiratory delivery platform
Derivative [Line Items]
Fair value loss (gain)								(68.5)
Senior Notes | Euro Senior Notes
Derivative [Line Items]
Long-term Debt, Gross | €																€ 3,000
Foreign currency translation								32.0
Senior Notes | 2018 Senior Notes (3.000% coupon)
Derivative [Line Items]
Long-term debt									499.4	[2]			499.6	[2]						$ 500.0
Debt instrument, interest rate, stated percentage	[2]																			3.00%
Senior Notes | 2020 Senior Notes (3.750% coupon)
Derivative [Line Items]
Long-term debt									499.8	[3]			499.9	[3]						$ 500.0
Debt instrument, interest rate, stated percentage	[3]																			3.75%
Senior Notes | 2016 Senior Notes (1.800% coupon)
Derivative [Line Items]
Debt instrument, interest rate, stated percentage	[4]																								1.80%
Aggregate principal amount																			$ 500.0
Senior Notes | 2016 Senior Notes (1.350% coupon)
Derivative [Line Items]
Debt instrument, interest rate, stated percentage	[5]																							1.35%
Aggregate principal amount															$ 500.0
Senior Notes | 2023 Senior Notes (3.125% coupon)
Derivative [Line Items]
Long-term debt	[6]								785.2				775.3
Debt instrument, interest rate, stated percentage	[6]																					3.125%
Net Investment Hedging
Derivative [Line Items]
Notional amount of derivative | €																	€ 288
Interest rate swaps
Derivative [Line Items]
Notional amount of derivative | €																	€ 750
April 2013 Swaps
Derivative [Line Items]
Notional amount of derivative				$ 1,000.0
Maximum length of time hedged in cash flow hedge, in years				10 years
Derivative instruments, gain (loss) reclassification from AOCE to income, estimated net amount to be transferred									32.9
August 2014 Swaps
Derivative [Line Items]
Notional amount of derivative			$ 575.0
Maximum length of time hedged in cash flow hedge, in years			10 years
Derivative instruments, gain (loss) reclassification from AOCE to income, estimated net amount to be transferred								22.4
July 2020 Senior Notes | Designated as hedging instrument
Derivative [Line Items]
Derivative instruments, gain (loss) reclassification from AOCE to income, estimated net amount to be transferred					$ 11.8			10.6
September 2015 Swaps Effective Date June 2016
Derivative [Line Items]
Notional amount of derivative																					$ 500.0
Loss on Cash Flow Hedge Ineffectiveness						$ 2.1
September 2015 Swaps Effective Date November 2016
Derivative [Line Items]
Notional amount of derivative																					$ 500.0
Other expense | Swedish krona denominated contracts
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net								128.6
Other expense | Interest rate swaps
Derivative [Line Items]
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net								0.0	(71.2)		0.0
Other Comprehensive Income (Loss) | September 2015 Swaps Effective Date June 2016
Derivative [Line Items]
Derivative, Loss on Derivative								$ 64.9
Contingent consideration | Minimum
Derivative [Line Items]
Rate used to discount net cash inflows to present values								0.90%
Contingent consideration | Maximum
Derivative [Line Items]
Rate used to discount net cash inflows to present values								9.80%
Other Noncurrent Liabilities
Derivative [Line Items]
Purchase consideration, contingent consideration	[7]								491.4		450.0		307.7
Acquisitions	[7]	1.2							18.0
Reclassifications	[7]							$ (169.8)	(15.0)
Accretion	[7]							41.7	38.4
Contingent consideration payments	[7]							0.5
Fair value loss (gain)	[1],[7]							(55.9)
Foreign currency translation	[7]							(0.4)
Other Noncurrent Liabilities | Jai Pharma Limited
Derivative [Line Items]
Acquisitions		$ 18.0
Other current liabilities
Derivative [Line Items]
Purchase consideration, contingent consideration	[8]								35.0		$ 20.0		256.9
Acquisitions	[8]							21.6	0.0
Reclassifications	[8]							169.8	15.0
Accretion	[8]							0.1	$ 0.0
Contingent consideration payments	[8]							44.4
Fair value loss (gain)	[1],[8]							74.8
Foreign currency translation	[8]							$ 0.0
Other current liabilities | Agila Specialties
Derivative [Line Items]
Purchase consideration, contingent consideration													$ 110.0										$ 20.0
Litigation Settlement, Amount					90.0
Change in contingent consideration, increase					$ 74.8

[1] Included in litigation settlements and other contingencies, net in the Consolidated Statements of Operations.

[2] Instrument is callable by the Company at any time at the greater of 100% of the principal amount and the sum of the present values of the remaining scheduled payments of principal and interest discounted at the U.S. Treasury rate plus 0.30% plus, in each case, accrued and unpaid interest.

[3] Instrument is callable by the Company at any time prior to the date that is one month prior to the instrument’s maturity date at the greater of 100% of the principal amount and the sum of the present values of the remaining scheduled payments of principal and interest discounted at the U.S. Treasury rate plus 0.35% plus, in each case, accrued and unpaid interest. On or after such date, the instrument is callable by the Company at 100% of the principal amount plus accrued and unpaid interest.

[4] Instrument matured on June 24, 2016, and the Company paid the principal amount of $500.0 million and final interest payment of $4.5 million upon maturity.

[5] Instrument matured on November 29, 2016, and the Company paid the principal amount of $500.0 million and final interest payment of $3.4 million upon maturity.

[6] Instrument is callable by the Company at any time at the greater of 100% of the principal amount and the sum of the present values of the remaining scheduled payments of principal and interest discounted at the U.S. Treasury rate plus 0.20% plus, in each case, accrued and unpaid interest.

[7] Included in other long-term obligations on the Consolidated Balance Sheets.

[8] Included in other current liabilities on the Consolidated Balance Sheets.